The case for earlier atrial fibrillation (AF) screening among Indigenous Australians is compelling, and it's not just about changing an age threshold. It's about matching prevention to the realities of risk. This is a critical issue that demands attention and action. Here's why:
Indigenous Australians develop AF earlier, experience stroke at younger ages, and are more likely to live with co-existing cardiovascular risks. They are also less likely to receive the therapies that reduce avoidable harm. This is a stark reality that highlights the need for a more tailored approach to AF screening and management.
The evidence is clear: AF screening should start at age 55 for Indigenous Australians, with earlier screening for those at higher stroke risk. This recommendation is not based on a special rule but on a risk-aligned response to the evidence. It's about recognizing that the pattern of risk for Indigenous Australians is different from the general population.
The benefits of earlier screening are significant. When AF is found earlier and treated well, disability can be prevented, independence preserved, and lives saved. This is a powerful message that should drive action. But it's not just about technology. Portable devices make AF easier to detect, but systems of care are crucial. When AF is detected, a structured clinical review is needed to confirm the diagnosis, assess stroke risk, and manage symptoms and rhythm.
The policy task is to make this routine. National leadership is needed to update AF screening recommendations in light of the evidence. This is a call to action for policymakers and healthcare providers. It's time to take a step back and think about how we can better match prevention to the realities of risk for Indigenous Australians.
In my opinion, the evidence is clear, and the need for action is urgent. We must not miss this opportunity to prevent stroke and improve health outcomes for Indigenous Australians. This is a matter of justice and equity, and it's time to act.
